Approval · Notice of Compliance 5392 · 1994
MULTI 12 INJECTION: Notice of Compliance 5392
Issued June 22, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5392
- Date
- June 22, 1994
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Multiple vitamin for total parenteral nutrition
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MULTI 12 INJECTION | 02100606 | Marketed |
Medicinal ingredients
- ASCORBIC ACID 20 MG per ML
- VITAMIN A 660 UNIT per ML
- VITAMIN D 40 UNIT per ML
- THIAMINE HCL 0.6 MG per ML
- RIBOFLAVIN-5-PHOSPHATE 0.72 MG per ML
- NICOTINAMIDE 8.6 MG per ML
- PYRIDOXINE HYDROCHLORIDE 0.8 MG per ML
- DEXPANTHENOL 3 MG per ML
- VITAMIN E 2 UNIT per ML
- BIOTIN 12 MG per ML
- FOLIC ACID 80 MCG per ML
- VITAMIN B12 1 MCG per ML